Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Immtech, University of North Carolina, Bill & Melinda Gates Foundation infectious news

IMM received a $5.1 million grant from a consortium led by the university to

Read the full 145 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE